Idaho is getting $625,000 in the settlement of a lawsuit with a prescription drug maker accused of selling products at false or inflated prices.
Attorney General Lawrence Wasden announced the resolution Monday with Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc.
The state sued the companies after conducting its own investigation into the average wholesale price companies post for specific drugs. This price is then used to compute the reimbursent to pharmacies that provide the drugs to Idaho Medicaid clients.
In one case, Wasden says his staff determined a 293 percent difference in the published wholesale price compared to the actual price for a Mylan product.
Since 2005, Wasden’s office has resolved 13 separate cases targeting inflated wholesale prescription drug prices and recovered more than $17.2 million from settling those lawsuits.
Was this article valuable?
Here are more articles you may enjoy.
Zurich CEO Says Staff Let Go as Regulator Finma Imposes Partial Sales Ban 
Florida Appeals Court Strikes Jury’s $335,000 Award in Universal Plumbing Claim 
eBay Settles Couple’s Harassment, Stalking Claims for $55.7 Million 
NYC Says Source of Legionnaires’ Disease Has Been Eliminated 
